Pacific Biosciences Of California | 净收入

金融业

USD

USD 803.16M

现金及等价物

USD 56.47M

USD 26.97M

USD 394.24M

USD 63.21M

USD 892M

股息收益率

0

USD -73.51M

USD -73.24M

796

EPS每股收益

USD -0.22

股本和储备

USD 36.09M

USD 10M

债务利息支出

USD 3.54M

USD 893.14M

USD 434.1M

USD -60.73M

USD 74.08M

USD -64.08M

普通股股本

USD 258K

681.33

USD -60.73M

USD 39.97M

销售和管理费用

USD 43.75M

USD 53.15M

贸易债权人

USD 16.36M

应收帐款人

USD 29.38M

	净收入	更改		日
Agilent	USD 305M		129M	2025-12
Bruker	USD 26M		88.4M	2025-12
Danaher	USD 1.2B		289M	2025-12
General Electric Aerospace	USD 2.54B		384M	2025-12
Illumina	USD 334M		184M	2025-12
Myriad Genetics	USD -27.4M		303.1M	2025-09
Pacific Biosciences Of California	USD -60.72M		112.59M	2024-09
Quidel	USD -733M		477.6M	2025-09
Revvity	USD 98.36M		51.71M	2025-12
Roche Holding	CHF 5.47B		1.76B	2025-12
Standard Biotools	USD -34.69M		1.23M	2025-09
Thermo Fisher Scientific	USD 1.96B		348M	2025-12
Waters	USD 225.21M		76.29M	2025-12

Pacific Biosciences Of California 净收入 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.